Novo Nordisk A/S(NVO) Q3
EPS: 0.89 USD; Forecast 0.73 USD
Revenue: 11.86B USD; Forecast 11.08B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-11-04